3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
5
Glioma
4
Multiple Myeloma
3
Carcinoma, Non-Small-Cell Lung
3
Neurofibromatosis 1
2
Neoplasms
2
Lymphoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Glioblastoma
2
Colorectal Neoplasms
2
Astrocytoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Histiocytosis, Langerhans-Cell
1
Ganglioneuroma
1
Interventions
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
Cisplatin
4
Cetuximab
4
cemiplimab
3
Radiotherapy
3
Platinum
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
(225)Ac-DOTA-c(RGDyK)
3
pembrolizumab
2
Radiation
2
Nivolumab
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
trastuzumab deruxtecan
1
niraparib
1
ipatasertib
1
durvalumab
1
dostarlimab
1
cabozantinib
1
atezolizumab
1
Ultrasonography
1
Transurethral Resection of Bladder
1
Tramadol
1
Taxes
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
trametinib
×
30 days
×
Clear all
No trials found.